LOGITECH INTERNATIONAL S.A. Quarterly Goodwill in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Logitech International S.A. quarterly Goodwill history and growth rate from Q1 2010 to Q3 2024.
  • Logitech International S.A. Goodwill for the quarter ending September 30, 2024 was $464M, a 0.5% increase year-over-year.
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $464M +$2.31M +0.5% Sep 30, 2024 10-Q 2024-10-24
Q2 2024 $462M +$8.08M +1.78% Jun 30, 2024 10-Q 2024-07-25
Q1 2024 $462M +$7.37M +1.62% Mar 31, 2024 10-Q 2024-10-24
Q4 2023 $464M +$9.51M +2.09% Dec 31, 2023 10-Q 2024-01-25
Q3 2023 $461M +$11.5M +2.56% Sep 30, 2023 10-Q 2023-10-26
Q2 2023 $454M +$2.71M +0.6% Jun 30, 2023 10-Q 2023-07-27
Q1 2023 $455M +$6.44M +1.44% Mar 31, 2023 10-K 2024-05-16
Q4 2022 $454M +$5.74M +1.28% Dec 31, 2022 10-Q 2023-01-26
Q3 2022 $450M +$535K +0.12% Sep 30, 2022 10-Q 2022-10-27
Q2 2022 $451M +$1.48M +0.33% Jun 30, 2022 10-Q 2022-07-28
Q1 2022 $448M +$18.6M +4.32% Mar 31, 2022 10-K 2024-05-16
Q4 2021 $449M +$47.7M +11.9% Dec 31, 2021 10-Q 2022-01-27
Q3 2021 $449M +$48.4M +12.1% Sep 30, 2021 10-Q 2021-10-28
Q2 2021 $450M +$48.8M +12.2% Jun 30, 2021 10-Q 2021-07-29
Q1 2021 $430M +$28.7M +7.16% Mar 31, 2021 10-K 2023-05-17
Q4 2020 $401M +$151K +0.04% Dec 31, 2020 10-Q 2021-01-21
Q3 2020 $401M +$57.3M +16.7% Sep 30, 2020 10-Q 2020-10-22
Q2 2020 $401M +$57.2M +16.7% Jun 30, 2020 10-Q 2020-07-23
Q1 2020 $401M +$57.2M +16.7% Mar 31, 2020 10-K 2022-05-18
Q4 2019 $401M +$53.5M +15.4% Dec 31, 2019 10-Q 2020-01-23
Q3 2019 $344M -$2.86M -0.83% Sep 30, 2019 10-Q 2019-10-25
Q2 2019 $344M +$68.3M +24.8% Jun 30, 2019 10-Q 2019-07-25
Q1 2019 $344M +$68.2M +24.8% Mar 31, 2019 10-K 2021-05-12
Q4 2018 $347M +$71.8M +26.1% Dec 31, 2018 10-Q 2019-01-24
Q3 2018 $347M +$75.4M +27.8% Sep 30, 2018 10-Q 2018-10-25
Q2 2018 $275M +$25.6M +10.3% Jun 30, 2018 10-Q 2018-08-02
Q1 2018 $275M +$25.7M +10.3% Mar 31, 2018 10-K 2020-05-27
Q4 2017 $276M +$25.8M +10.3% Dec 31, 2017 10-Q 2018-01-25
Q3 2017 $271M +$21.4M +8.56% Sep 30, 2017 10-Q 2017-11-01
Q2 2017 $250M +$4.9M +2% Jun 30, 2017 10-Q 2017-07-27
Q1 2017 $250M +$31.5M +14.4% Mar 31, 2017 10-K 2019-05-17
Q4 2016 $250M +$31.5M +14.4% Dec 31, 2016 10-Q 2017-02-06
Q3 2016 $250M +$31.6M +14.5% Sep 30, 2016 10-Q 2016-10-27
Q2 2016 $245M +$26.6M +12.2% Jun 30, 2016 10-Q 2016-07-29
Q1 2016 $218M +$11K +0.01% Mar 31, 2016 10-K 2018-05-21
Q4 2015 $218M -$125M -36.5% Dec 31, 2015 10-Q 2016-01-22
Q3 2015 $218M -$126M -36.6% Sep 30, 2015 10-Q 2015-10-23
Q2 2015 $218M -$127M -36.7% Jun 30, 2015 10-Q 2015-07-24
Q1 2015 $218M -$1.2M -0.55% Mar 31, 2015 10-K 2017-05-26
Q4 2014 $343M -$1.6M -0.46% Dec 31, 2014 10-Q 2015-01-27
Q3 2014 $344M -$804K -0.23% Sep 30, 2014 10-Q 2014-11-26
Q2 2014 $345M +$539K +0.16% Jun 30, 2014 10-Q 2014-11-14
Q1 2014 $219M -$122M -35.7% Mar 31, 2014 10-K 2016-05-23
Q4 2013 $345M -$277K -0.08% Dec 31, 2013 10-Q 2014-01-30
Q3 2013 $345M -$216M -38.6% Sep 30, 2013 10-Q 2013-11-05
Q2 2013 $344M -$214M -38.3% Jun 30, 2013 10-Q 2013-08-07
Q1 2013 $341M -$219M -39.1% Mar 31, 2013 10-K 2015-06-05
Q4 2012 $345M -$215M -38.3% Dec 31, 2012 10-Q 2013-02-05
Q3 2012 $561M +$737K +0.13% Sep 30, 2012 10-Q 2012-11-06
Q2 2012 $558M +$11M +2.02% Jun 30, 2012 10-Q 2012-08-06
Q1 2012 $561M +$13.3M +2.44% Mar 31, 2012 10-K 2014-11-13
Q4 2011 $560M +$6.31M +1.14% Dec 31, 2011 10-Q 2012-02-06
Q3 2011 $560M +$6.55M +1.18% Sep 30, 2011 10-Q 2011-11-07
Q2 2011 $547M -$6.28M -1.13% Jun 30, 2011 10-Q/A 2011-09-06
Q1 2011 $547M -$6.28M -1.13% Mar 31, 2011 10-K/A 2013-08-07
Q4 2010 $554M Dec 31, 2010 10-Q 2011-02-07
Q3 2010 $554M Sep 30, 2010 10-Q 2010-11-08
Q2 2010 $553M Jun 30, 2010 10-Q/A 2010-08-25
Q1 2010 $553M Mar 31, 2010 10-K 2012-05-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.